참고문헌
- K. Mak and M. Pichika, "Artificial intelligence in drug development: present status and future prospects," Drug Discovery Today, vol. 24, no. 3, pp. 773-780, Mar. 2019. https://doi.org/10.1016/j.drudis.2018.11.014
- N. Fleming, "How artificial intelligence is changing drug discovery", Nature, vol. 557, pp. 55-57, May. 2018. https://doi.org/10.1038/d41586-018-05267-x
- G. Hessler and K. Baringhaus, "Artificial Intelligence in Drug Design", Molecules, vol. 23, no. 10, pp. 2520, 2018. https://doi.org/10.3390/molecules23102520
- H. Chen, O. Engkvist, Y. Wang, M. Olivecrona, and T. Blaschke, "The rise of deep learning in drug discovery," Drug Discovery Today, vol. 23, no. 6, pp. 1241-1250, Jun. 2018. https://doi.org/10.1016/j.drudis.2018.01.039
- I. M. Kapetanovic, "Computer-aided drug discovery and development (CADDD): in-silico-chemico-biological approach," Chem. Biol. Interact, vol. 171, pp. 165-176, 2008. https://doi.org/10.1016/j.cbi.2006.12.006
- S. P. Leelananda and S. Lindert, "Computational methods in drug discovery," Beilstein J. Org. Chem., vol. 12, pp. 2694-2718, 2016. https://doi.org/10.3762/bjoc.12.267
- L. Zhang, J. Tan, D. Han, and H. Zhu, "From machine learning to deep learning: progress in machine intelligence for rational drug discovery," Drug Discovery Today, vol. 22, no. 11, pp. 1680-1685, Nov. 2017. https://doi.org/10.1016/j.drudis.2017.08.010
- L. Patel, T. Shukla, X. Huang, D. Ussery, and S. Wang, "Machine Learning Methods in Drug Discovery," Molecules, vol. 25, pp. 5277, 2020. https://doi.org/10.3390/molecules25225277
- S. Woo, "Drug Discovery Enhanced by Artificial Intelligence," Biomedical Journal of Scientific & Technical Research, vol. 12, no. 1, Dec. 2018.
- A. Bender and I. Cortes-Ciriano, "Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet," Drug Discovery Today, vol. 26, no. 2, pp. 511-524, 2021. https://doi.org/10.1016/j.drudis.2020.12.009
- Y. Lo, S. E. Rensi, W. Torng, and R. B. Altman, "Machine learning in chemoinformatics and drug discovery," Drug Discovery Today, vol. 23, no. 8, pp. 1538-1546, 2018. https://doi.org/10.1016/j.drudis.2018.05.010
- K. T. Nho and S. J. Lee, "chemoinformatics for drug discovery," Journal of Scientific & Technological Knowledge Infrastructure, no. 3, pp. 68-75, 2000.
- A. Varnek and I. Baskin, "Machine learning methods for property prediction in chemoinformatics: Quo Vadis?," Journal of Chemical Information and Modeling, vol. 52, pp. 1413-1437, 2012. https://doi.org/10.1021/ci200409x
- E. J. Bjerrum, "SMILES enumeration as data augmentation for neural network modeling of molecules," arXiv: 1703.07076, 2017.
- D. Rogers and M. Hahn, "Extended-Connectivity Fingerprints," Journal of Chemical Information and Modeling, vol. 50, no. 5, pp. 742-754, 2010. https://doi.org/10.1021/ci100050t
- J. Vamathevan, D. Clark, P. Czodrowski, I. Dunham, E. Ferran, G. Lee, B. Li, A. Madabhushi, P. Shah, M. Spitzer, and S. Zhao, "Applications of machine learning in drug discovery and development," Nature Review of Drug Discovery, vol. 18, no. 6, pp. 463-477, Jun. 2019. https://doi.org/10.1038/s41573-019-0024-5
- E. Gawehn, J. Hiss, and G. Schneider, "Deep Learning in Drug Discovery," Molecular Informatics, vol. 35, no. 1, pp. 3-14, Jan. 2016. https://doi.org/10.1002/minf.201501008
- Y. Yang, S. J. Adelstein, and A. I. Kassis, "Target discovery from data mining approaches," Drug Discovery. Today, vol. 14, pp. 147-154. 2009. https://doi.org/10.1016/j.drudis.2008.12.005
- T. Katsila, G. A. Spyroulias, G. P. Patrinos, and M. Matsoukasa, "Computational approaches in target identification and drug discovery," Computational and Structural Biotechnology Journal, vol. 14, pp. 177-184, 2016. https://doi.org/10.1016/j.csbj.2016.04.004
- T. Huang, H. Mi, C. Lin, L. Zhao, L. Zhong, F. Liu, G., A. Lu, and Z. Bian, "MOST: most-similar ligand based approach to target prediction," BMC Bioinformatics, vol. 18, no. 1, 2017.
- T. Rodrigues and G. J. Bernardes, "Machine learning for target discovery in drug development," Current Opinion in Chemical Biology, vol. 56, pp. 16-22, 2020. https://doi.org/10.1016/j.cbpa.2019.10.003
- D. Gao, Q. Chen, Y. Zeng, M. Jiang, and Y. Zhang, "Application of Machine Learning on Drug Target Discovery," Current Drug Metabolism, 2020.
- R. Chen, X. Liu, S. Jin, J. Lin, and J. Liu, "Machine Learning for Drug-Target Interaction Prediction," Molecules, vol. 23, no. 9:2208, 2018 https://doi.org/10.3390/molecules23092208
- G. Y. Joo, "AlphaFold: Ai-based protein 3D structure," Technical Report, Apr. 2019.
- AlphaFold [Internet]. Available: https://deepmind.com/blog/alphafold/.
- J. Pereira, E. Caffarena, C. Dos Santos, and C. N. Boosting, "Docking-Based Virtual Screening with Deep Learning," J. Journal of Chemical Information and Modeling, vol. 56, pp. 2495-2506, 2016. https://doi.org/10.1021/acs.jcim.6b00355
- M. Ragoza, J. Hochuli, E. Idrobo, J. Sunseri, and D. Koes, "Protein-ligand scoring with convolutional neural networks," Journal of Chemical Information and Modeling, vol. 57, pp. 942-957, 2017. https://doi.org/10.1021/acs.jcim.6b00740
- C. Reda, E. Kaufmann, and A. Delahaye-Duriezade, "Machine learning applications in drug development," Computational and Structural Biotechnology Journal, vol. 18, pp. 241-252, 2020. https://doi.org/10.1016/j.csbj.2019.12.006
- M. Elbadawi, S. Gaisford, and A. W. Basit, "Advanced machine-learning techniques in drug discovery," Drug Discovery Today, vol. 26, no. 3, pp. 769-777, Mar. 2021. https://doi.org/10.1016/j.drudis.2020.12.003
- V. Svetnik, A. Liaw, C. Tong, J. Culberson, R. Sheridan, and B. Feuston, "Random forest: a classification and regression tool for compound classification and QSAR modeling," Journal of Chemical Information and Computer Sciences, vol. 43, pp. 1947-1958, 2003. https://doi.org/10.1021/ci034160g
- K. Lee, M. Lee, and D. Kim, "Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server," BMC Bioinformatics, vol. 18, no. 567, 2017.
- H. Sun, "A naive bayes classifier for prediction of multidrug resistance reversal activity on the basis of atom typing," Journal of Medical Chemistry, vol. 48, pp. 4031-4039, 2005. https://doi.org/10.1021/jm050180t
- C. Ratanamahatana and D. Gunopulos, "Feature selection for the naive bayesian classifier using decision trees," Applied Artificial Intelligence, vol. 17, no. 5-6, 2003.
- C. Cortes and V. Vapnik, "Support-vector networks," Machine Learning, vol. 20, pp. 273-297, 1995. https://doi.org/10.1007/BF00994018
- J. D. MacCuish and N. E. MacCuish, "Clustering in Bioinformatics and Drug Discovery," CRC Press, 2019.
- G. Mohamed, M. Hamdy, and B. Ashraf, "Clustering of chemical data sets for drug discovery," 2014 9th International Conference on Informatics and Systems, Dec. 2014.
- A. Giuliani, "The application of principal component analysis to drug discovery and biomedical data," Drug Discovery Today, vol. 22, no. 7, pp. 1069-1076, 2017. https://doi.org/10.1016/j.drudis.2017.01.005
- A. Rifaioglu, H. Atas, M. Martin, R. Cetin-Atalay, V. Atalay, and T. Dogan, "Recent applications of deep learning and machine intelligence on in silico drug discovery, methods, tools and databases," Brief Bioinformatics, vol. 20, pp. 1878-1912, 2019. https://doi.org/10.1093/bib/bby061
- I. Baskin, D. Winkler, and I. Tetko, "A renaissance of neural networks in drug discovery," Expert Opin. Drug Discov., vol. 11, pp. 785-795, 2016. https://doi.org/10.1080/17460441.2016.1201262
- Y. Bengio, "Learning deep architectures for AI," Foundations and Trends in Machine Learning, vol. 2, no. 1, pp. 1-55, Jan. 2009. https://doi.org/10.1561/2200000006
- Y. LeCun, Y. Bengio, and G. Hinton, "Deep learning," Nature, vol. 521, pp. 436-444, 2015. https://doi.org/10.1038/nature14539
- I. Goldberg, "Deep Learning in Drug Discovery and Medicine; Scratching the Surface," Molecules, vol. 23,no. 9:2384, 2018. https://doi.org/10.3390/molecules23092384
- H. Chen, O. Engkvist, Y. Wang, M. Olivecrona, and T. Blaschke, "The rise of deep learning in drug discovery," Drug Discovery Today, vol. 23, no. 6, pp. 1241-1250, Jun. 2018. https://doi.org/10.1016/j.drudis.2018.01.039
- K. Manish, N. Abhigyan, T. P. Singh, A. S. Ethayathulla, and P. Kaur, "Evolving scenario of big data and Artifcial Intelligence (AI) in drug discovery," Molecular Diversity, vol. 25, pp. 1439-1460, 2021. https://doi.org/10.1007/s11030-021-10256-w
- A. Arabi, "Artificial intelligence in drug design: algorithms, applications, challenges and ethics," Future Drug Discovery, vol. 3, no. 2, 2021.
- H. Lee, R. Grosse, R. Ranganath, and A. Y. Ng, "Unsupervised learning of hierarchical representations with convolutional deep belief networks," Communications of the ACM, vol. 54, pp. 95-103, 2011.
- J. Yasonik, "Multiobjective de novo drug design with recurrent neural networks and nondominated sorting," Journal of Cheminformatics, vol. 12, no. 14, 2020.
- I. Wallach, M. Dzamba, and A. Heifets, "AtomNet: A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery," CoRR, 2015.
- DeepSite [Internet]. Available: https://playmolecule.org/deepsite/.
- J. Jimenez, M. Skalic, G. Martinez-Rosell, and G. De Fabritiis, "K DEEP: Protein-Ligand Absolute Binding Affinity Prediction via 3D-Convolutional Neural Networks," Journal of Chemical Information and Modeling, vol. 58, no. 2, pp. 287-296, 2018. https://doi.org/10.1021/acs.jcim.7b00650
- A. Bender and I. Cortes-Ciriano, "Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data," Drug Discovery Today, vol. 26, no. 4, pp. 1040-1052, Apr. 2021. https://doi.org/10.1016/j.drudis.2020.11.037
- R. C. Mohs and N. H. Greig, "Drug discovery and development: role of basic biological research," Alzheimer's & Dementia, vol. 3, no. 4, pp. 651-657, 2017. https://doi.org/10.1016/j.trci.2017.10.005